Page 55 - Market Outlook

Sensex can hit 80,000 by December 2023 in bull-case, says Morgan Stanley

As their base-case, however, Morgan Stanley sees the S&P BSE Sensex to scale up to 68,500 levels - up 10 per cent from the current levels.

From banks to IT, analysts bet on these sectors as markets hit record highs

Metals, state-owned oil marketing companies, and export/global economy-linked sectors may not see any meaningful rally

Sensex hits record high, Nifty at new 1-year high: Factors behind the rally

Global stock markets jumped on Thursday after minutes of the US Federal Reserve's November policy meeting hinted at a possible moderation in the pace of interest rate hikes

It will be a 'bottoms-up' market in 2023: Sachin Shah of Emkay

Geopolitical tensions, and high energy and commodity prices are expected to continue in 2023. Therefore, the outlook for Indian equity markets will depend on the actual growth in the domestic economy

Indian markets are likely to underperform peers in the short-run: Analysts

Among the lot, US equities still have a lot of room to catch up as the US Federal Reserve (US Fed) slows its pace of rate hikes, analysts say

MCX Gold may scale Rs 53,350 as trend turns positive; Silver eyes Rs 63,725

The near-term support for MCX Gold futures now shifted higher to Rs 52,000-level, whereas Silver futures likely to seek support near 200-DMA at Rs 60,800.

Analysts see more legs to the market rally amid intermittent corrections

Analysts think it will not be a runaway rally from here on as the market valuations seem expensive

Upside for Gold capped around Rs 52,570; Silver to test hurdle at Rs 60,800

The MCX Gold futures are likely to face resistance around Rs 51,135, above which the up move may still be capped at Rs 52,570. Silver futures have failed to sustain above the 200-DMA since late April.

Vinay Rajani of HDFC Securities recommends Buy on KIMS, United Spirits

On the broader market outlook, the technical analyst sees 18,350 as the next resistance for the Nifty 50, and support at 17,800-level.

Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%

What do expect from pharma stocks over the next few weeks? Here's what technical charts suggest.

StanChart posts 40% jump in quarterly profit, raises income outlook

Standard Chartered posted a 40% increase in quarterly profit, as the emerging markets-focused bank benefited from a sharp rise in income on higher interest rates

A less predictable outlook: How will Indian economy do in Samvat 2079?

While the frothier end of the market of unicorns has already seen a low tide when it comes to fresh funding, the more sober end of the market might provide a positive surprise, writes T N Ninan

Support zone for Nifty shifted higher to 17,200-17,300, says Vinay Rajani

Among individual stocks, the technical analyst from HDFC Securities recommends buying IndusInd Bank and Mahindra CIE.

We prefer a bottom-up approach in this environment: Satish Ramanathan

SATISH RAMANATHAN, chief investment officer for Equity at JM Financial Asset Management shares his outlook for the markets and his sector preferences

Pivot point at 50,350 for MCX Gold this week; Silver may see volatility

The bears are likely to have the upper hand as long as MCX Gold futures trade below Rs 50,350 this week; Near resistance on the upside is seen at Rs 50,900.

High food price-led inflation worrisome for markets, policymakers: Analysts

High inflation will keep the markets on edge as they were hoping that the global central banks, especially the US Fed and the RBI will go soft on rate hikes over the next few months

Indian markets are in midst of global quagmire: Harendra Kumar, Elara Sec

Equity markets are in a state of suspended animation - it is conflicted on which way to move. While global markets, and the rupee are flashing red signs, India is holding up due to its 'Atmanirbharta

Here's why Vinay Rajani is bullish on KIMS, Pfizer; bearish on Nifty

On the broader market outlook, the technical analyst from HDFC Securities says that the indicators and oscillators have turned bearish on the short term charts for the Nifty 50.

TCS needs to breakout over Rs 3,150-level for fresh rally, chart says

There is an "Inverse Head and Shoulder" pattern getting established on the daily chart. Technically, this pattern breakout over Rs 3,150 levels would add aggressive bets on the stock.

Mehul Kothari recommends Buy on CAMS, Pfizer; Check Why

According to the technical analyst from Anand Rathi, CAMS can rally to Rs 2,700, while Pfizer can be bought for a target of Rs 4,700.